Abstract

Background: The Pfizer COVID-19 vaccine has been widely administered in many countries, including Saudi Arabia, to combat the global COVID-19 pandemic. The present study aimed at assessing the demographic distribution of Pfizer COVID-19 vaccination between Al-Qunfudhah governorate population, as well as to evaluate short and long-term side effects, also clear the safety perception of Pfizer COVID-19 vaccination among the participants.
Methods: In this cross-sectional study we observed the effects of the Pfizer COVID-19 vaccine in Al-Qunfudhah City, capturing data at one point in time from 271 participants. The focus is on the reported side effects. We analyzed data collected via an online questionnaire, using Statistical Package for the Social Sciences, version 26.0.
Results: We conducted our study on 271 participants in the community in Al-Qunfudhah City, Saudi Arabia. We found that the majority of respondents (83.8%) had received three doses of the Pfizer COVID-19 vaccine, with common side effects including pain at the injection site, fever, fatigue, and headaches. A significant portion experienced myocarditis, pericarditis, and other serious conditions like thrombosis and facial paralysis, but nausea was less common. Over half considered the vaccine safe and somewhat effective, relying on Ministry of Health bulletins for information, and are likely to recommend vaccination to others.
Conclusion: Our study sheds light on crucial facets of Pfizer-BioNTech mRNA COVID-19 vaccination, with a focus on the demographic prevalence and alignment with previous research patterns. It emphasizes the correlation among demographic characteristics, health behaviors, and the received urgency of global vaccination efforts against the pandemic, particularly with the Pfizer COVID-19 vaccine.

Key words: Pfizer COVID-19 vaccine, long-term side effects, short-term side effects, Al-Qunfudhah City